levdobutamine
{{cs1 config|name-list-style=vanc|display-authors=6}}
{{Infobox drug
| drug_name =
| image = Levdobutamine.svg
| width =
| caption =
| pronounce =
| tradename =
| Drugs.com =
| MedlinePlus =
| licence_CA =
| licence_EU =
| DailyMedID =
| licence_US =
| pregnancy_AU =
| pregnancy_category =
| dependency_liability =
| addiction_liability =
| routes_of_administration =
| class = Sympathomimetic; β1-Adrenergic receptor agonist; Positive inotrope
| ATC_prefix =
| ATC_suffix =
| legal_status =
| bioavailability =
| protein_bound =
| metabolism =
| metabolites =
| onset =
| elimination_half-life =
| duration_of_action =
| excretion =
| CAS_number = 61661-06-1
| CAS_supplemental =
| PubChem = 688441
| IUPHAR_ligand =
| DrugBank =
| ChemSpiderID = 599903
| UNII = 0PE6UXH3WG
| KEGG =
| ChEBI = 59805
| ChEMBL = 1367478
| NIAID_ChemDB =
| PDB_ligand =
| synonyms = Levodobutamine; (S)-Dobutamine; LY-206243
| IUPAC_name = 4-[2-
| C=18 | H=23 | N=1 | O=3
| SMILES = C[C@@H](CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
| StdInChI = 1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3/t13-/m0/s1
| StdInChIKey = JRWZLRBJNMZMFE-ZDUSSCGKSA-N
}}
Levdobutamine ({{Abbrlink|INN|International Nonproprietary Name}}; developmental code name LY-206243; also known as (S)-dobutamine) is a sympathomimetic, selective β1-adrenergic receptor agonist, and positive inotrope which was never marketed.{{cite book | vauthors = Morton IK, Hall JM | title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms | publisher=Springer Netherlands | year=2012 | isbn=978-94-011-4439-1 | url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA164 | access-date=27 February 2025 | page=164}}{{cite book | vauthors = Milne G, Zeman E | title=Ashgate Handbook of Cardiovascular Agents: An International Guide to 1900 Drugs in Current Use: An International Guide to 1900 Drugs in Current Use | publisher=Taylor & Francis | series=Routledge Revivals | year=2017 | isbn=978-1-351-74240-5 | url=https://books.google.com/books?id=ZlkPEAAAQBAJ&pg=PA228 | access-date=27 February 2025 | page=228}} It is the (S)-enantiomer of dobutamine.
References
{{Reflist}}
{{Adrenergic receptor modulators}}
{{Phenethylamines}}
Category:Beta1-adrenergic agonists
Category:Drugs developed by Eli Lilly and Company
Category:4-Hydroxyphenyl compounds
{{Cardiovascular-drug-stub}}